We are international

November 2011 Archives : Discussions About IMF Web Site Content

Most Commented
Most Recent

Advocacy Update - November 15, 2011

By IMF Admin on November 26, 2011 11:33 AM | No Comments

Advocacy Update - November 15, 2011

STEP 10: NEW TRIALS: HOW TO FIND THEM - REFERENCES

By IMF Admin on November 24, 2011 12:49 PM | No Comments

STEP 10: NEW TRIALS: HOW TO FIND THEM - REFERENCES

Phase III REVLIMID Clinical Trials

By IMF Admin on November 23, 2011 5:53 PM | No Comments

Phase III REVLIMID Clinical Trials

Lorna Newlin

By IMF Admin on November 23, 2011 5:26 PM | No Comments

Lorna Newlin

IMFer Runs Cleveland Marathon

By IMF Admin on November 23, 2011 5:10 PM | No Comments

IMFer Runs Cleveland Marathon

Understanding Mozobil^® (plerixafor injection)

By IMF Admin on November 22, 2011 9:22 PM | No Comments

Understanding Mozobil^® (plerixafor injection)

STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES

By IMF Admin on November 22, 2011 3:58 PM | No Comments

STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES

IMFer Runs Cleveland Marathon

By IMF Admin on November 17, 2011 8:44 AM | No Comments

IMFer Runs Cleveland Marathon

Pomalidomide + carfilzomib trial to open.

By IMF Admin on November 11, 2011 6:11 AM | 1 Comment

Pomalidomide + carfilzomib trial to open.

Myeloma Canada Announces Recipient of this Year?s Research Grant

By IMF Admin on November 10, 2011 6:28 PM | No Comments

Myeloma Canada Announces Recipient of this Year?s Research Grant

Sign up TODAY for Advocacy Training Two-Part Online Series!

By IMF Admin on November 10, 2011 2:18 PM | No Comments

Sign up TODAY for Advocacy Training Two-Part Online Series!

FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease

By IMF Admin on November 7, 2011 8:25 AM | No Comments

FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease

Phase III REVLIMID Clinical Trials

By IMF Admin on November 7, 2011 12:46 AM | No Comments

Phase III REVLIMID Clinical Trials

New Jersey Advocate Persuades Representative to Co-Sponsor HR 2746

By IMF Admin on November 1, 2011 8:09 PM | No Comments

New Jersey Advocate Persuades Representative to Co-Sponsor HR 2746

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

By IMF Admin on November 1, 2011 8:00 PM | No Comments

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

By IMF Admin on November 1, 2011 7:45 AM | No Comments

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

« October 2011 | Main Index | Archives | December 2011 »